La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Dermapharm Holding Gestione
Gestione criteri di controllo 4/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Hans-Georg Feldmeier
Amministratore delegato
€1.4m
Compenso totale
| Percentuale dello stipendio del CEO | 59.7% |
| Mandato del CEO | 7.1yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 2yrs |
| Durata media del Consiglio di amministrazione | 7.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Here's Why Dermapharm Holding (ETR:DMP) Has A Meaningful Debt Burden
Sep 28
Dermapharm Holding SE Beat Revenue Forecasts By 6.7%: Here's What Analysts Are Forecasting Next
Aug 31Dermapharm Holding SE's (ETR:DMP) P/E Still Appears To Be Reasonable
Aug 17It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope
Jun 21These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24
The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €83m |
| Mar 31 2024 | n/a | n/a | €57m |
| Dec 31 2023 | €1m | €821k | €62m |
| Sep 30 2023 | n/a | n/a | €95m |
| Jun 30 2023 | n/a | n/a | €123m |
| Mar 31 2023 | n/a | n/a | €146m |
| Dec 31 2022 | €1m | €800k | €134m |
| Sep 30 2022 | n/a | n/a | €176m |
| Jun 30 2022 | n/a | n/a | €185m |
| Mar 31 2022 | n/a | n/a | €211m |
| Dec 31 2021 | €1m | €800k | €210m |
| Sep 30 2021 | n/a | n/a | €162m |
| Jun 30 2021 | n/a | n/a | €123m |
| Mar 31 2021 | n/a | n/a | €95m |
| Dec 31 2020 | €736k | €411k | €86m |
Compensazione vs Mercato: La retribuzione totale di Hans-Georg ($USD 1.52M ) è circa la media per le aziende di dimensioni simili nel mercato German ($USD 1.61M ).
Compensazione vs guadagni: La retribuzione di Hans-Georg è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Hans-Georg Feldmeier
7.1yrs
Mandato
€1,375,000
Compensazione
Dr. Hans-Georg Feldmeier is the Chief Executive Officer and Chairman of the Management Board at Dermapharm Holding SE and also serves as Member of the Management Board from August 2017.
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Chairman of the Management Board | 7.1yrs | €1.38m | Nessun dato | |
| CFO, Chief Compliance Officer & Member of Management Board | 1.8yrs | €617.00k | Nessun dato | |
| Chief Marketing Officer & Member of Management Board | 2yrs | €612.00k | Nessun dato | |
| Head of Investor Relations & Corporate Communications | no data | Nessun dato | Nessun dato |
2.0yrs
Durata media
Gestione esperta: Il team dirigenziale di DMP è considerato esperto (durata media dell'incarico 2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Independent Member of Supervisory Board | 6.7yrs | €80.00k | Nessun dato | |
| Chairman of the Supervisory Board | 7.1yrs | €80.00k | Nessun dato | |
| Independent Vice Chairman of the Supervisory Board | 7.1yrs | €80.00k | Nessun dato |
7.1yrs
Durata media
68yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di DMP sono considerati esperti (durata media dell'incarico 7 anni).